Stock Market News

Tempest Therapeutics stock rises on EMA Orphan Drug Designation

Jun 5, 2025 - 15:50
 0
Tempest Therapeutics stock rises on EMA Orphan Drug Designation
Read More

Tags:

Previous Article

Ocugen stock rises on Korean licensing deal for gene therapy

Next Article

Circle Internet Group IPO indicated to open at $42-$44 after pricing at $31

Related Posts

G-III Apparel, ABM Industries, and more set to report earnings Friday

G-III Apparel, ABM Industries, and more set to report e...

Jun 5, 2025  0

Be underweight U.S. equities, neutral on the Magnificent 7: Deutsche Bank

Be underweight U.S. equities, neutral on the Magnificen...

May 14, 2025  0

Lem Holding reports sales drop of 24.4% in FY 2024/25, sees signs of recovery

Lem Holding reports sales drop of 24.4% in FY 2024/25, ...

May 27, 2025  0